中成药治疗复发性阿弗他口炎的疗效与安全性:一项系统综述
该系统综述检索9个电子数据库,纳入11项随机对照试验和1项临床对照试验,比较中成药与维生素片或安慰剂治疗复发性阿弗他口炎。结果显示中成药有助于缓解溃疡疼痛、减少发作持续时间和频率;报告的不良反应包括胃痛、腹胀、腹泻、轻度恶心和胃肠道不适,均为自限性或停药后可缓解。作者认为中成药可能通过缓解疼痛、减小溃疡面积及减少发作持续时间和频率来有效治疗复发性阿弗他口炎。
要点
- 中成药有助于缓解复发性阿弗他口炎患者的溃疡疼痛。
- 中成药可减少复发性阿弗他口炎的发作持续时间和频率。
- 报告的不良反应包括胃痛、腹胀、腹泻、轻度恶心和胃肠道不适,均为自限性或停药后可缓解。
核心结论
- 中成药可能通过缓解疼痛、减小溃疡面积及减少发作持续时间和频率来有效治疗复发性阿弗他口炎。
研究设计与样本
- 系统综述检索9个电子数据库,纳入11项随机对照试验和1项临床对照试验,比较中成药与维生素片或安慰剂治疗复发性阿弗他口炎。
主要发现
- 中成药有助于缓解复发性阿弗他口炎患者的溃疡疼痛。
- 中成药有助于减少复发性阿弗他口炎的发作持续时间和频率。
- 报告的不良反应包括胃痛、腹胀、腹泻、轻度恶心和胃肠道不适,均为自限性或停药后可缓解。
临床怎么用
- 作者认为中成药可能通过缓解疼痛、减小溃疡面积及减少发作持续时间和频率来有效治疗复发性阿弗他口炎。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent aphthous stomatitis (RAS) is the most common chronic oral mucosal condition of the oral cavity. Investigators in clinical trials have evaluated the effectiveness of Chinese patent medicines in the treatment of RAS. However, the results are conflicting rather than conclusive. To evaluate the efficacy and safety of Chinese patent medicines for the treatment of RAS, the authors conducted a systematic review. TYPES OF STUDIES REVIEWED: The authors searched 9 electronic databases to identify randomized controlled trials (RCTs) or potential clinical controlled trials (CCTs), published in any language, in which the investigators compared Chinese patent medicines with vitamin tablets or placebos for the treatment of RAS. RESULTS: The authors included 11 RCTs and 1 CCT in the review. Results showed that Chinese patent medicines were beneficial for patients with RAS in relieving ulcer pain and reducing the duration and frequency of attacks. The reported adverse effects of Chinese patent medicines included stomachache, abdominal distention, diarrhea, mild nausea, and gastrointestinal discomfort, which were either self-limiting or could be relieved by treatment cessation. CONCLUSIONS AND PRACTICAL IMPLICATIONS: Chinese patent medicines may be effective for treatment of RAS by means of relieving pain and reducing ulcer size and episode duration and frequency.
引用
- Zhou P, Mao Q, Hua H, et al. Efficacy and safety of Chinese patent medicines in the treatment of recurrent aphthous stomatitis: A systematic review. J Am Dent Assoc. 2017. PMID: 28062049. doi:10.1016/j.adaj.2016.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。